CLINICAL_TRIALS ClinicalTrials.gov record update

A Prospective,Multicenter, Phase II Study to Evaluate the Contribution of the Imaging TEP to the Expression of intégrines αvβ3 for the Characterization of the Residual Masses of Non-seminoma Tumors at the End of Chemotherapy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02317393
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:39.214961+00:00
Published At: 2020-07-09T00:00:00+00:00
Record Updated At: 2020-07-09
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Non-seminomatous Germ Cell Tumors", "Metastasis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-07-09"
protocolSection.identificationModule.nctId: "NCT02317393"
protocolSection.identificationModule.officialTitle: "A Prospective,Multicenter, Phase II Study to Evaluate the Contribution of the Imaging TEP to the Expression of int\u00e9grines \u03b1v\u03b23 for the Characterization of the Residual Masses of Non-seminoma Tumors at the End of Chemotherapy"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.